Patients with measurable metastatic gastric adenocarcinoma involving the peritoneum , and resectable to `` no evidence of disease '' were randomized to gastrectomy , metastasectomy , HIPEC , and systemic FOLFOXIRI ( GYMS arm ) or FOLFOXIRI alone ( SA arm ) .